NewLink Genetics was an American biotechnology company based in Ames, Iowa. It merged with Lumos Pharma in March 2020.[1]
Organization
BioProtection Systems was a wholly-owned subsidiary of NewLink.[2]
External links
Miller, L. (2020, March 18). NewLink Genetics Stockholders Approve Merger with Lumos Pharma. GlobeNewswire News Room. https://web.archive.org/web/20230225200007/https://www.globenewswire.com/en/news-release/2020/03/18/2002543/15114/en/NewLink-Genetics-Stockholders-Approve-Merger-with-Lumos-Pharma.html ↩︎
Link, G. (2014, August 5). NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine. Lumos Pharma. http://archive.today/2023.02.25-194304/http://investors.linkp.com/news-releases/news-release-details/newlink-genetics-corporation-through-its-wholly-owned-subsidiary ↩︎
